Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
The official podcast of the Australasian Society for Intellectual Disability (ASID). We bring you the latest in Australian and New Zealand research into improving the rights and quality of life for people with intellectual disability. Find out more about ASID at our website http://asid.asn.au/ or follow us on social media: Twitter @ASID_Ltd Facebook: @asid.asn.au .
…
continue reading
1
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)
29:05
29:05
나중에 재생
나중에 재생
리스트
좋아요
좋아요
29:05
Featuring a slide presentation and related discussion from Dr Joshua Richter, including the following topics: Similarities and differences between the cellular targets and mechanisms of action of BCMA- and non-BCMA-directed bispecific antibodies for multiple myeloma (MM) (0:00) Antitumor activity observed with teclistamab and elranatamab for relaps…
…
continue reading
1
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
41:54
41:54
나중에 재생
나중에 재생
리스트
좋아요
좋아요
41:54
Featuring an interview with Dr Joshua Richter, including the following topics: Management of cytokine release syndrome after bispecific antibody therapy; importance of clinical trials in the multiple myeloma (MM) treatment paradigm (0:00) Similarities and differences between and efficacy and tolerability of BCMA- and non-BCMA-directed bispecific an…
…
continue reading
1
Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers
1:29:58
1:29:58
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:29:58
Featuring perspectives from Ms Blanca Ledezma, Dr Stacey Stein, Ms Amanda K Wagner and Dr Mark Yarchoan, including the following topics: Introduction (0:00) Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma (HCC) (9:40) Role of Immunotherapy in Intermediate-Stage HCC (17:02) First-Line Therapy for Advanced HCC (19:56) Immunotherapy in the M…
…
continue reading
1
HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
1:16:27
1:16:27
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:16:27
Featuring perspectives from Dr Adam M Brufsky, including the following topics: Review of Local Therapy (0:00) Treatment Advances for HER2 Positive Early-Stage Breast Cancer (18:34) Case: A woman in her early 60s with ER-positive, HER2-positive (IHC 3+) with infiltrating ductal carcinoma who received T-DM1 with an aromatase inhibitor (19:37) Case: A…
…
continue reading
1
Endometrial Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer
1:30:22
1:30:22
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:30:22
Featuring perspectives from Ms Jennifer Filipi, Ms Kathryn Lyle, Dr David O’Malley and Dr Shannon N Westin, including the following topics: Introduction (0:00) Incidence and Biology of Endometrial Cancer (EC) (9:30) Use of Immune Checkpoint Inhibitors as Monotherapy for EC (23:24) First-Line Therapy for Primary Advanced or Recurrent EC (28:28) Lenv…
…
continue reading
1
Prostate Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Prostate Cancer
59:38
59:38
나중에 재생
나중에 재생
리스트
좋아요
좋아요
59:38
Featuring perspectives from Dr Andrew J Armstrong and Ms Brenda Martone, including the following topics: Introduction: Overview of Prostate Cancer; Hormonal Therapy (0:00) Radiopharmaceuticals for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) (24:11) Biomarker Testing for mCRPC; PARP Inhibitors for mCRPC (49:33) NCPD inf…
…
continue reading
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia | Faculty Presentation 2: Available and Emerging Nontargeted Therapies for AML — Naval Daver, MD CME information and select publications저자 Dr. Neil Love
…
continue reading
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia | Faculty Presentation 1: Current and Emerging Role of Biomarker-Directed Therapeutic Approaches for Patients with Acute Myeloid Leukemia (AML) — Courtney D DiNardo, MD, MSCE CME information and select publications…
…
continue reading
1
Acute Myeloid Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
1:02:08
1:02:08
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:02:08
Featuring perspectives from Dr Naval Daver and Dr Courtney D DiNardo, including the following topics: Introduction (0:00) Available and Emerging Nontargeted Therapies for Acute Myeloid Leukemia (AML) —Dr Daver (6:47) Current and Emerging Role of Biomarker-Directed Therapeutic Approaches for Patients with AML —Dr DiNardo (32:58) CME information and …
…
continue reading
1
Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation
1:29:08
1:29:08
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:29:08
Featuring perspectives from Ms Marianne J Davies, Dr Alexander I Spira, Ms Jillian Thompson and Dr Helena Yu, including the following topics: Introduction (0:00) The Importance of EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) (7:02) The Role of Osimertinib in Managing Localized and Locally Advanced NSCLC with an EGFR Mutation (11:58) Establish…
…
continue reading
1
Metastatic Triple-Negative Breast Cancer | Virtual Case Library: Metastatic Triple-Negative Breast Cancer
2:12:44
2:12:44
나중에 재생
나중에 재생
리스트
좋아요
좋아요
2:12:44
Featuring perspectives from Dr Julia Foldi, Dr Laura Huppert, Dr Rita Nanda, Dr Saba Shaikh and Dr Sara M Tolaney, including the following topics: Introduction: Overview of metastatic triple-negative breast cancer (mTNBC) Current and emerging strategies for patients with mTNBC (0:00) First-line treatment of mTNBC — Chemotherapy with or without immu…
…
continue reading
1
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
1:07:30
1:07:30
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:07:30
Featuring perspectives from Dr Matthew D Galsky, including the following topics: HER2 alterations in urothelial cancer and current targeting approaches (0:00) Key findings supporting the use of trastuzumab deruxtecan for patients with HER2-overexpressing cancers as part of the Phase II DESTINY-PanTumor02 study (9:39) Targeting of HER2 using disitam…
…
continue reading
1
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)
1:03:30
1:03:30
나중에 재생
나중에 재생
리스트
좋아요
좋아요
1:03:30
Featuring a slide presentation and related discussion from Dr Sunnie Kim, including the following topics: Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer — Dr Kim (0:00) Case: A man in his mid 50s with poorly differentiated mismatch repair-deficient advanced gastric cancer receives first-line nivolumab/ipilimumab (49:22) …
…
continue reading